Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.
- DOI
- 10.12659/msm.910702
- Published
- 2018 Oct 12
- Container
- Medical science monitor : international medical journal of experimental and clinical research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.12659/msm.910702,
title = {Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.},
author = {Li L and Huizhi L and Binu W and Xinxin D and Longjun W and Liping Y and Yingying Z},
year = {2018},
journal = {Medical science monitor : international medical journal of experimental and clinical research},
doi = {10.12659/msm.910702},
url = {https://doi.org/10.12659/msm.910702}
}RIS
TY - JOUR TI - Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways. AU - Li L AU - Huizhi L AU - Binu W AU - Xinxin D AU - Longjun W AU - Liping Y AU - Yingying Z PY - 2018 JO - Medical science monitor : international medical journal of experimental and clinical research DO - 10.12659/msm.910702 UR - https://doi.org/10.12659/msm.910702 ER -
APA
L, L., L, H., W, B., D, X., W, L., Y, L., & Z, Y. (2018). Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.. Medical science monitor : international medical journal of experimental and clinical research. https://doi.org/10.12659/msm.910702
Source records
- pubmed · retrieved 2026-09-25T00:03:56.375Z
- europe-pmc · retrieved 2026-09-25T00:03:56.388Z